TOLERION, INC.

Profile

Company Names

TOLERION, INC.

Addresses

131 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

415-795-5800

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$43,005,087.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-01-16 
$19,999,998.00 
$39,999,993.00 
$19,999,995.00 
Equity 
1
2017-12-28 
$23,005,089.00 
$29,755,087.00 
$6,749,998.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GRAEME 
 
CURIE 
EXECUTIVE OFFICER
TOLERION, INC.
JOHN 
 
DONOVAN 
EXECUTIVE OFFICER, DIRECTOR
LENDINGCLUB CORP   |  RENAVANCE PHARMA, INC.   |  ALIOS BIOPHARMA INC   |  TIOMA THERAPEUTICS, INC.   |  CONCENTRIC ANALGESICS, INC.   |  OLEA NETWORKS, INC.   |  TOLERION, INC.   |  LUCATA CORP   |  NOVASIGNAL CORP.   |  CRESTA INTELLIGENCE INC.   |  HUNTINGTON FERMI FUSION, LLC
ALEXANDER 
 
FLEMING 
EXECUTIVE OFFICER
EXSULIN CORP   |  TOLERION, INC.
SCOTT 
 
GEYER 
EXECUTIVE OFFICER
TOLERION, INC.
RANDOLPH 
 
JOHNSON 
EXECUTIVE OFFICER
TOLERION, INC.
PAUL 
 
MANNING 
DIRECTOR
GEN9, INC.   |  ENZYMATICS INC   |  AVEXIS, INC.   |  VERRICA PHARMACEUTICALS INC.   |  ARCHERDX, INC.   |  ADVANTAGENE, INC.   |  TOLERION, INC.   |  BLUE MARLIN THERAPEUTICS, INC.
SEAN 
 
STALFORT 
DIRECTOR
VERRICA PHARMACEUTICALS INC.   |  ADVANTAGENE, INC.   |  XALUD THERAPEUTICS, INC.   |  TOLERION, INC.   |  SALIOGEN THERAPEUTICS, INC.   |  TAYSHA GENE THERAPIES, INC.   |  BLUE MARLIN THERAPEUTICS, INC.
LAWRENCE 
 
STEINMAN 
DIRECTOR
ATRECA, INC.   |  TOLERION, INC.   |  180 LIFE SCIENCES CORP.   |  PASITHEA THERAPEUTICS CORP.
JAMES 
 
STUTZ 
EXECUTIVE OFFICER
TIOMA THERAPEUTICS, INC.   |  TOLERION, INC.   |  NEURONA THERAPEUTICS, INC
STEPHEN 
 
ZACHARY 
DIRECTOR
DICE MOLECULES HOLDINGS, LLC   |  SELUX DIAGNOSTICS, INC.   |  SANDS CAPITAL LIFE SCIENCES PULSE FUND, L.P.   |  SANDS CAPITAL LIFE SCIENCES PULSE FUND C-1, L.P.   |  SANDS CAPITAL LIFE SCIENCES PULSE FUND C-1-GP, L.P.   |  SANDS CAPITAL LIFE SCIENCES PULSE FUND-GP, L.P.   |  TOLERION, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-02-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-28 
2020-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-01-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CIM SECURITIES, LLC
120852